Keyhole Therapeutics
PrivateCompany Overview
Keyhole Therapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California.
Keyhole Therapeutics is a biotechnology company that develops first-in-class immunotherapies for cancer and autoimmune diseases by targeting exosome-mediated immune suppression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Keyhole Therapeutics Comparables
Compare Keyhole Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EV Therapeutics | 80% | |
| Aluda Pharmaceuticals | 74% | |
| Relay Therapeutics | 65% |
For institutional investors. Book with your work email.
Keyhole Therapeutics Funding Rounds
Historical fundraising activity
Keyhole Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Keyhole Therapeutics's valuation, stock price, and market status.
Is Keyhole Therapeutics a public or private company?
Keyhole Therapeutics is a private company.
What is the current stock price of Keyhole Therapeutics?
Keyhole Therapeutics is a private company, so its shares have no public market price. Caplight tracks Keyhole Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Keyhole Therapeutics worth (valuation)?
Valuation information for Keyhole Therapeutics is not publicly available.
Can I buy Keyhole Therapeutics stock?
Keyhole Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Keyhole Therapeutics's last funding round?
Funding round information for Keyhole Therapeutics is not publicly available.
Who are the main investors in Keyhole Therapeutics?
Investor information for Keyhole Therapeutics is not publicly disclosed.
Will Keyhole Therapeutics IPO soon?
No public IPO plans have been announced for Keyhole Therapeutics.
How can I track Keyhole Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Keyhole Therapeutics's shares on secondary markets.